Author

M. Lopez-Cavestany

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

B. Cagir· 1 shared J. D. Greenlee· 1 shared K. Liu· 1 shared M. R. King· 1 shared N. Ortiz-Otero· 1 shared T. Subramanian· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Cagir

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Oxaliplatin Resistance in Colorectal Cancer Enhances TRAIL Sensitivity Via Death Receptor 4 Upregulation and Lipid Raft Localization

J. D. Greenlee, M. Lopez-Cavestany, N. Ortiz-Otero, K. Liu, T. Subramanian, B. Cagir, M. R. King

This study shows oxaliplatin-resistant colorectal cancer cells become more sensitive to TRAIL due to increased DR4 expression, palmitoylation, and lipid raft localization.

bioRxiv · Mar 5, 2021Cancer Biology